Show simple item record

dc.contributor.authorObeagu, Emmanuel Ifeanyi
dc.contributor.authorObeagu, Getrude Uzoma
dc.contributor.authorHabimana, Jean Bosco
dc.date.accessioned2023-10-31T09:34:15Z
dc.date.available2023-10-31T09:34:15Z
dc.date.issued2023
dc.identifier.citationEmmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu, Jean Bosco Habimana; (2023), Iron Deficiency Anaemia in Children; International Research in Medical and Health Sciences, ; (6-4): 26-32;en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3227
dc.description.abstractTwo-thirds of anemia in children worldwide, of which IDA accounts for 20 to 25% of cases, are caused by iron deficiency, which is a significant global health burden. Despite treatment, unfortunately, IDA can have neuropsychiatric effects and is strongly associated with cognitive decline throughout childhood and adolescence 60% of African children under 5 years of age are anemic, of which IDA accounts for 50% of the burden. However, iron salt supplementation has a significant impact on preventing or reducing anemia. It is estimated that since the late 1990s, about 2 billion people worldwide have ID disease, which causes half of all anemia cases. The majority of people with iron deficiency who do not have anemia have no symptoms and can only be identified by a screening test. The most common symptom of iron deficiency anemia is pallor, also commonly seen in the nail bed, conjunctiva, palmar crease, and nail bed. In the absence of iron and ferritin studies, haemoglobin can be a sensitive test to distinguish IDA from other forms of microcytic anemia.en_US
dc.language.isoen_USen_US
dc.publisherInternational Research in Medical and Health Sciencesen_US
dc.subjectChildrenen_US
dc.subjectIronen_US
dc.subjectIron Deficiency Anaemiaen_US
dc.subjectNutrientsen_US
dc.titleIron Deficiency Anaemia in Childrenen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record